Transurethral Resection of Prostate Syndrome
6
1
1
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
17%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Hemoglobin-to-red Blood Cell Distribution Width Ratio and Hypothermia for Elderly Patient
The Hemodynamic Effects of Hypertonic Saline Preload Versus Coload Measured by Non-invasive Cardiometry in Patients Undergoing TURP Surgery
Artery Embolization vs Operation of Benign Prostate Hyperplasia
Transurethral Prostate Resection (TURP) vs. Prostate Artery Embolization (PAE)
Risk Factors and Impact of Anesthesia Techniques on Myocardial Infarction Following Transurethral Resection of the Prostate
Prophylaxis Versus Treatment for TURP Syndrome.